effects. For these purposes, a series of 1,8-naphthalimide derivatives were designed and synthesized, and their structure-activity relationships (SAR) as hCYP1B1 inhibitors were analyzed. Following three rounds SAR studies, several potent hCYP1B1 inhibitors were discovered, among which compound was selected for further investigations owing to its extremely potent anti-hCYP1B1 activity (IC = 0.040 nM)
人细胞色素P450 1B1酶(hCYP1B1)是hCYP1亚家族的成员,通过参与多种代谢途径在多种疾病中发挥着至关重要的作用。尽管之前已经报道了一系列有效的 hCYP1B1
抑制剂,但其中大多数也充当芳基烃受体 (AhR) 激动剂,可以上调 hCYP1B1 的表达,然后抵消其在生命系统中的抑制潜力。本研究旨在开发新型有效的 hCYP1B1
抑制剂,该
抑制剂在活细胞中效果良好,但没有 AhR 激动剂作用。为此,设计并合成了一系列1,8-
萘二甲
酰亚胺衍
生物,并分析了它们作为hCYP1B1
抑制剂的构效关系(
SAR)。经过三轮
SAR 研究,发现了几种有效的 hCYP1B1
抑制剂,其中由于其极强的抗 hCYP1B1 活性(IC = 0.040 nM)及其在活细胞中阻断 AhR 转录活性,因此选择该化合物进行进一步研究。抑制动力学分析表明,以混合抑制方式有效抑制hCYP1B1,显示值为21.71